Supplementary Material 0813.docx (636.18 kB)
Download file

epi-2021-0230 Suppl. Material

Download (636.18 kB)
dataset
posted on 16.09.2021, 09:39 by Yan Li, Bingjing LiBingjing Li, Lixiang Li, Yu Yu, Xiang Gu, Chang Liu, Xinggui Long, Yanbo Yu, Xiuli Zuo

Supplementary Table 1. Overall sample information and patients’ characteristics.

Supplementary Table 2. Primer sequences for qRT-PCR

Supplementary Table 3. Four miRNAs expression level of UC patients and HCs in miRNA sequencing data

Supplementary Figure 1 Correlation analysis of test samples. (A) CircRNAs data correlation analysis of test samples. (B) MiRNAs data correlation analysis of test samples. (C) MRNAs data correlation analysis of test samples.

Supplementary Figure 2 Comparative analysis of hsa_circ_0001021 from UC patients treated with or without medicine. (A) Comparative analysis of hsa_circ_0001021 from UC patients treated with or without 5-ASA. (B) Comparative analysis of hsa_circ_0001021 from UC patients treated with or without steroids. NS, nonsignificant.

Funding

National Natural Science Foundation of China

National Natural Science Foundation of China

Find out more...

National Natural Science Foundation of China Key Research and Development Program of Shandong Province

Taishan Scholars Program of Shandong Province.

History